Literature DB >> 10192517

Immunoregulatory mechanisms of the eye.

J W Streilein1.   

Abstract

Immunity to protect the eye from invading pathogens is an absolute requirement for the preservation of vision. However, immune responses carry their own threat of tissue damage, due chiefly to the participation of non-specific inflammation. Because of its delicate microanatomy, the visual axis is vulnerable to distortion (and resulting blindness) from relatively trivial amounts of intraocular inflammation. Therefore, regulation of expression of immunity in the eye is critical to preservation of vision. Regulation of ocular immunity is one expression of the general phenomenon of regional immunity in which local tissue factors mold immune responses to local purposes. Ocular immune privilege is an extreme example of regional immunity. Immune privilege is an active, rather than a passive, process in which regulatory molecules and cells of the eye modulate both the induction and the expression of immunity to eye-derived antigens. Immune privilege is achieved primarily through unique features of the eye, ranging from special microanatomic factors (blood:eye barrier, absence of lymphatic draining), to soluble factors secreted by ocular cells into the ocular microenvironment, to regulatory molecules constitutively expressed on the surfaces of ocular cells. In general, the most important consequence of regulation of ocular immune responses is the virtual elimination of immunogenic inflammation from the eye. While this enables the eye to receive immune protection without the threat of blinding inflammation, it also renders the eye vulnerable to those pathogens whose elimination requires the participation of inflammatory molecules and cells.

Entities:  

Mesh:

Year:  1999        PMID: 10192517     DOI: 10.1016/s1350-9462(98)00022-6

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  20 in total

Review 1.  Experimental corneal allograft rejection.

Authors:  Bryan M Gebhardt; Weiyun Shi
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Novel mechanisms of class II major histocompatibility complex gene regulation.

Authors:  Michael Radosevich; Santa Jeremy Ono
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

3.  Influence of race and age on aqueous humor levels of transforming growth factor-beta 2 in glaucomatous and nonglaucomatous eyes.

Authors:  Rupal H Trivedi; Matthew Nutaitis; David Vroman; Craig E Crosson
Journal:  J Ocul Pharmacol Ther       Date:  2010-10-29       Impact factor: 2.671

Review 4.  New insight into the role of the complement in the most common types of retinopathy-current literature review.

Authors:  Martyna Chrzanowska; Anna Modrzejewska; Monika Modrzejewska
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

5.  CD4+ T-Cell Responses Mediate Progressive Neurodegeneration in Experimental Ischemic Retinopathy.

Authors:  Thi Hong Khanh Vu; Huihui Chen; Li Pan; Kin-Sang Cho; Djoeke Doesburg; Eric F Thee; Nan Wu; Elisa Arlotti; Martine J Jager; Dong Feng Chen
Journal:  Am J Pathol       Date:  2020-05-08       Impact factor: 4.307

Review 6.  Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions.

Authors:  Michelle C Callegan; Michael Engelbert; David W Parke; Bradley D Jett; Michael S Gilmore
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 7.  Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions.

Authors:  Michelle C Callegan; Michael S Gilmore; Meredith Gregory; Raniyah T Ramadan; Brandt J Wiskur; Andrea L Moyer; Jonathan J Hunt; Billy D Novosad
Journal:  Prog Retin Eye Res       Date:  2007-01-22       Impact factor: 21.198

8.  Level of herpes simplex virus type 1 latency correlates with severity of corneal scarring and exhaustion of CD8+ T cells in trigeminal ganglia of latently infected mice.

Authors:  Kevin R Mott; Catherine J Bresee; Sariah J Allen; Lbachir BenMohamed; Steven L Wechsler; Homayon Ghiasi
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

9.  Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis).

Authors:  Reza Dana
Journal:  Trans Am Ophthalmol Soc       Date:  2007

10.  TIGIT+ A2Ar-Dependent anti-uveitic Treg cells are a novel subset of Tregs associated with resolution of autoimmune uveitis.

Authors:  Fauziyya Muhammad; Dawei Wang; Trisha McDonald; Marisa Walsh; Kayla Drenen; Alyssa Montieth; C Stephen Foster; Darren J Lee
Journal:  J Autoimmun       Date:  2020-03-20       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.